Heron Therapeutics (HRTX) Gross Profit (2017 - 2026)
Heron Therapeutics' (HRTX) quarterly Gross Profit came in at $24.1 million in Q1 2026, down 20.93% YoY from $30.4 million in Q1 2025, and down 18.31% on a QoQ basis from $29.5 million in Q4 2025.
Heron Therapeutics (HRTX) Gross Profit (2017 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 10 years of Gross Profit data on file, last reported at $24.1 million in Q1 2026.
- Quarterly Gross Profit fell 20.93% year-over-year to $24.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.2 million (down 2.43% YoY) and the FY2025 annual result came in at $113.6 million, up 7.5% from the prior year.
- Gross Profit retreated to $24.1 million in Q1 2026, from $29.5 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $30.6 million in Q4 2024 to a low of $11.5 million in Q2 2022.
- A 5-year average of $21.1 million and a median of $24.1 million in 2026 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2024 — Gross Profit jumped 119.8% — and 2026, when it fell 20.93%.
- Tracing HRTX's Gross Profit over 5 years: stood at $17.4 million in 2022, then surged by 39.92% to $24.3 million in 2023, then rose by 25.48% to $30.6 million in 2024, then declined by 3.55% to $29.5 million in 2025, then retreated by 18.31% to $24.1 million in 2026.
- The last three Gross Profit figures came in at $24.1 million (Q1 2026), $29.5 million (Q4 2025), and $26.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.09 Mn |
| Jun 30, 2026 | 26.09 Mn |
| Mar 31, 2026 | 24.07 Mn |
| Mar 31, 2026 | 24.07 Mn |
| Dec 31, 2025 | 29.47 Mn |
| Dec 31, 2025 | 29.47 Mn |
| Sep 30, 2025 | 26.30 Mn |
| Sep 30, 2025 | 26.30 Mn |
| Jun 30, 2025 | 27.34 Mn |
| Jun 30, 2025 | 27.34 Mn |
| Mar 31, 2025 | 30.45 Mn |
| Mar 31, 2025 | 30.45 Mn |
| Dec 31, 2024 | 30.55 Mn |
| Dec 31, 2024 | 30.55 Mn |
| Sep 30, 2024 | 23.35 Mn |
| Sep 30, 2024 | 23.35 Mn |
| Jun 30, 2024 | 25.51 Mn |
| Jun 30, 2024 | 25.51 Mn |
| Mar 31, 2024 | 26.23 Mn |
| Mar 31, 2024 | 26.23 Mn |